#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

In vitro maturation of oocytes – our experiencies in prevention of ovarian hyperstimulation syndromein patients at risk of OHSS


Authors: A. Ďurechová;  A. Calamar;  L. Maršík;  J. Války
Published in: Prakt Gyn 2007; 11(4): 184-187

Publikováno v Praktickej gynekológii 2006; 13(4): 283–286.

Overview

In vitro maturation (IVM) of oocytes is a method of infertility treatment used in human medicine from the end of the 80ties of the last century. This is a safe possibility of infertility treatment of women at the risk of ovarian hyperstimulation syndrome(OHSS), low responders and is lowering the costs for infertility treatment by IVF.

Key words:
in vitro maturation (IVM) – polycystic ovaries (PCO) – ovarian hyperstimulation syndrome (OHSS)


Sources

1. Andersen A et al. Assisted reproductive technology in Europe 2001. Results generated from European registers by ESHRE. Hum Reprod 2005; 20(5): 1158–1176.

2. Edwards RG. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature 1965; 208: 349–351.

3. Freidén B et al. Birth of a healthy infant after in vitrooocyte maturation and ICSI in a woman with diminished ovarian response: Case report. Hum Reprod 2005; 20(9): 2556–2558.

4. Hreinsson J et al. Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturatio in a clinical in vitro maturation programme: a randomized study. Hum Reprod 2003; 18(10): 2131–2136.

5. Cha KY et al. Pregnancy after in vitro fertilisation of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in donor oocyte program. Fertil Steril 1991; 55: 109–113.

6. Chian RC et al. Pregnancies resulting from in vitro maturated oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin. Fertil Steril 1999; 72: 639–642.

7. Mikkelsen AL et al. In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod 1999; 14(7): 1847–1851.

8. Pincus G et al. The comparative behavior of mammalian eggs in vitro end in vivo. J Exp Med 1935; 62: 655–675.

9. Raj S et al. The use of gonadotrophin for the industion of ovulation in women with polycystic ovary syndrome. Fertil Steril 1977; 28: 1280–1284.

10. Ri-Cheng Ch. In vitro maturation of immature oocytes for infertile women in PCOS. Reprod Biomed Online 2004; 8(5): 547–552.

11. Rosenwaks Z. Donor eggs:their applicaion in modern reproductive technologies. Fertil Steril 1987; 47: 895–909.

12. Russell JB et al. Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming. Fertil Steril 1997; 67: 616–620.

13. Trounson A et al. In vitro maturation and fertilization and developmental competence of oocytes recovered from untraeted polycystic ovarian patients. Fertil Steril 1994; 62: 353–362.

14. Wynn P et al. Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in vitro maturation. Hum Reprod 1998; 13(11): 3132–3138.

15. Yu-Hung L et al. Combinatio of FSH priming and hCG priming for in vitro maturation of human oocytes. Hum Reprod 2003; 18(8): 1632–1636.

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#